Mikhail Blagosklonny is an oncology professor who works with the Roswell Park Cancer Institute. Blagosklonny is also a researcher who focuses on molecular biology, cellular biology, and clinical investigations on anticancer therapeutics. He has also carried out tests on tumor suppressors, cell cycle, apoptosis, and mitosis. As he carries out scientific tests, he usually examines on how cancerous cells can be killed and how they respond to different types of drugs. He also focuses on how aging and age-related diseases can be treated.
Mikhail Blagosklonny has written 300 reviews, book chapters and articles themed on medical topics, such as oncology and aging. He also works for Cell Cycle as the chief editor. He works with other editors in publishing articles posted on Oncoscience, Oncotarget, and Aging journals. His previous editing roles benefited the Internal Journal of Cancer, Cell Death, and Differentiation, The American Journal of Pathology, as well as Autophagy. View Mikhail’s profile on Loop.
Rapamycin as an Anti-aging Drug Component
Based on his research findings, Blagosklonny concluded that rapamycin could be used as an alternative to anti-aging medicines. Blagosklonny also believes that the available anti-aging drugs can be used in developing effective solutions for life extension. Some drugs are thought to increase the lifespan of people by ten years. Rapamycin is a compound that can be used to develop anti-aging drugs. The compound was first used in organ transplants for suppressing the immune system. It was concluded that rapamycin could lengthen the lifespan of animals by 14 percent.
Blagosklonny believes that one of the major causes of age-related diseases and death is immune system aging. Furthermore, old people tend to fall ill quickly and respond slowly to vaccines because of their weak immune systems. In ant-aging studies, slow response to drugs by the body is a sign of worn out cells. Rapamycin can be used to boost the immunities of people and decrease their susceptibility to diseases. Blagosklonny concluded that one of the ways of living longer is by adopting healthy dieting plan. Rapamycin relies on the mTOR protein for it to be effective. The protein is also affected by high-calorie intake. Visit ResearchGate to know more about Mikhail’s latest work.